One in vivo study using the TMEV model suggested TF reduces excitotoxicity by demonstrating a decreasing trend of glutamate excess on MR spectroscopy after treatment [182].
← all excerpts
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple Sclerosis.
1
—
—